Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia
Conditions: Good Prognosis Metastatic Gestational Trophoblastic Tumor; Hydatidiform Mole; Non-Metastatic Gestational Trophoblastic Tumor; Uterine Corpus ChoriocarcinomaInterventions: Biological: Dactinomycin; Drug: MethotrexateSponsors: Gynecologic Oncology Group; Eastern Cooperative Oncology Group; National Cancer Institute (NCI)Completed - verified December 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials